Investor Relations Captor Therapeutics ®
Information on transaction in Company shares under Article 19 MAR
Publication date:
Publication time:
Current report no. 6/2026
Drafting date: 26 February 2026
Subject: Information on transaction in Company shares under Article 19 MAR
Legal basis: Article 19(3) MAR – information on transactions carried out by persons discharging managerial responsibilities
The Management Board of Captor Therapeutics S.A. based in Wrocław ("the Company") informs that on 26 February 2026 it received from Sylvain Cottens, SVP Chemistry, the notification regarding transactions on the Company's shares under Article 19(1) of the MAR Regulation.
The content of the notification is attached to this report.